Trabectedin, a drug acting on both cancer cells and the tumour microenvironment.
about
Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedinTrabectedin for Soft Tissue Sarcoma: Current Status and Future PerspectivesThe value of trabectedin in the treatment of soft tissue sarcomaPatterns of Chromosomal Aberrations in Solid TumorsTrabectedin for advanced soft tissue sarcomas: optimizing useImmune cell promotion of metastasisMolecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and TreatmentAdvances in sarcoma diagnostics and treatmentMarine-Derived Pharmaceuticals - Challenges and OpportunitiesCurrent classification, treatment options, and new perspectives in the management of adipocytic sarcomasTrabectedin in soft tissue sarcomasMarine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancerIncreased expression of interferon signaling genes in the bone marrow microenvironment of myelodysplastic syndromes.Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcomaRecent Advances in the Development of Antineoplastic Agents Derived from Natural ProductsTrabectedin Followed by Irinotecan Can Stabilize Disease in Advanced Translocation-Positive Sarcomas with Acceptable Toxicity.Central venous access related adverse events after trabectedin infusions in soft tissue sarcoma patients; experience and management in a nationwide multi-center study.Marine Antibody-Drug Conjugates: Design Strategies and Research Progress.Targeted therapy for soft tissue sarcomas in adolescents and young adults.Pharmacological treatment for uterine leiomyosarcomas.Malignant cardiac tumors: diagnosis and treatment.Trabectedin for the treatment of breast cancer.Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms.Treatment of advanced soft tissue sarcoma: efficacy and safety of trabectedin, a multitarget agent, and update on other systemic therapeutic options.Tumor-associated macrophages and anti-tumor therapies: complex links.Drug-induced hepatotoxicity in cancer patients - implication for treatment.Trabectedin for the treatment of soft tissue sarcomas.Efficacy of trabectedin for the treatment of liposarcoma.Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer.Tumour-associated macrophages as treatment targets in oncology.An Updated Review on Marine Anticancer Compounds: The Use of Virtual Screening for the Discovery of Small-Molecule Cancer Drugs.Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and ImmunotherapiesTargeting the EWS-FLI1 transcription factor in Ewing sarcoma.Managing sarcoma: where have we come from and where are we going?Response to trabectedin in a patient with advanced synovial sarcoma with lung metastases.The Danish experience with trabectedin treatment for metastatic sarcoma: Importance of hyponatremia.Beyond clinical trials in advanced soft tissue sarcoma: what to expect from trabectedin treatment? Foreword.A drug development perspective on targeting tumor-associated myeloid cells.Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners.
P2860
Q26738346-E948A949-BA6F-4BD6-B447-35321FD46B86Q26745502-55BC36CB-F07E-4C41-B98A-78329E941138Q26772855-D330A732-6C9A-44E5-BF3D-BD01FE576EABQ26786127-2ACBB34F-667A-4896-8E92-9DD22E1A7D32Q26860365-DF352206-990B-4DE6-8B31-CAA6D1470F49Q26991724-88F8B409-2050-4F9C-8DB7-AA20915A0837Q28066904-DF74B67F-B890-4AD8-8F72-9370506E3741Q28069695-3A2A8B04-D02D-4828-9505-3276D92FCBB3Q28075572-D5E0476C-9305-4640-886D-AA491D5B1409Q28076210-38400DAB-B95A-4E1F-B259-DD0DE508FAA7Q28085505-D82A5B0B-1EAA-445D-A27B-53C6C0A11E52Q33834080-32F223D3-5C5B-42AC-8668-625484966833Q34996149-F356EF1B-01DD-4FB2-80FA-1EBD36CF939AQ35214418-0489A43B-DD5B-4DD6-AF3E-7939C25FDEE6Q36078294-B1060122-2C8A-420F-9DEF-E76725C75CAFQ36273796-7443C375-B75E-473E-8BFF-5267367A548DQ37397097-5328E935-4594-442D-AAEF-2EEF5D5723EEQ37615789-A4FAC034-7704-44D2-934E-3F38D614C1ADQ37628646-A58D7147-EFBA-4692-B1FD-4D49904753E8Q37742014-A960D2F7-E1E8-439C-B356-78616AC87DD4Q38270671-DDEA3D1F-59FD-4EFB-B565-6F41E7203944Q38559451-45EA51EF-7426-409F-AAED-299E51361475Q38642314-94830509-8520-4A70-B974-DFCA2FD3E880Q38722106-183A5FA1-1CF0-490F-A1C0-C65B45B5F8C4Q38731757-D619EBAF-A870-438D-9802-A632F6968158Q38766176-95EA7F7E-FD84-44AE-887E-150274247B5FQ38845891-F1AB1FA9-3888-4AC3-A1D3-FE11713588B4Q38872192-1C6FCF1A-859F-4D3C-BC0B-8FAF38534FC5Q38951318-1377D0CA-1697-4B9E-B2D9-099582BDB4A9Q39096364-5FD4D0C4-2901-46B2-94BE-ED91B7C8A48BQ39100693-D9BC8977-5917-496C-B23F-B5AB4AA7B9FEQ39394159-32B09BF1-9890-4294-88F7-D87CB3F80F1AQ41011622-592E5024-5BDE-4465-9A3F-4651C132DA93Q41159521-8A987537-EE10-4866-87D5-34A438B1774CQ41988197-AAE09A9D-FBD5-4D77-8ADD-1DEA8AC1F99EQ42195995-0DFCE779-07A0-4050-BF40-E8CE974F13D1Q44301485-955DA29C-8D20-4F10-9BFF-55ABE85DE123Q48467038-2086E9D3-5C24-479A-9C49-F32A52319278Q48652546-38362A1F-6B30-4CEA-8C3F-B2F72F36FEBCQ49805542-13BDC5B9-2B61-4685-9B15-7A7CFE396241
P2860
Trabectedin, a drug acting on both cancer cells and the tumour microenvironment.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Trabectedin, a drug acting on both cancer cells and the tumour microenvironment.
@en
type
label
Trabectedin, a drug acting on both cancer cells and the tumour microenvironment.
@en
prefLabel
Trabectedin, a drug acting on both cancer cells and the tumour microenvironment.
@en
P2860
P921
P356
P1476
Trabectedin, a drug acting on both cancer cells and the tumour microenvironment.
@en
P2093
C M Galmarini
P2860
P2888
P304
P356
10.1038/BJC.2014.149
P407
P5008
P577
2014-04-22T00:00:00Z
2014-08-12T00:00:00Z
P5875
P6179
1006338022